Cytosorbents (CTSO) Non-Current Debt (2016 - 2026)
Cytosorbents' (CTSO) quarterly Non-Current Debt came in at $10.3 million in Q1 2026, down 27.31% YoY from $14.2 million in Q1 2025, and down 38.12% on a QoQ basis from $16.7 million in Q4 2025.
Cytosorbents (CTSO) Non-Current Debt (2016 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 10 years of Non-Current Debt data on file, last reported at $10.3 million in Q1 2026.
- Quarterly Non-Current Debt fell 27.31% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (down 27.31% YoY) and the FY2025 annual result came in at $16.7 million, up 19.08% from the prior year.
- Non-Current Debt slipped to $10.3 million in Q1 2026, from $16.7 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $16.7 million in Q4 2025 to a low of $1.9 million in Q1 2024.
- A 5-year average of $9.7 million and a median of $12.0 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2024 — Non-Current Debt slumped 61.51% — and 2025, when it jumped 635.61%.
- Tracing CTSO's Non-Current Debt over 5 years: stood at $5.0 million in 2022, then sank by 49.14% to $2.5 million in 2023, then jumped by 450.4% to $14.0 million in 2024, then gained by 19.08% to $16.7 million in 2025, then tumbled by 38.12% to $10.3 million in 2026.
- The last three Non-Current Debt figures came in at $10.3 million (Q1 2026), $16.7 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 3.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.09 Mn |
| Mar 31, 2026 | 10.31 Mn |
| Dec 31, 2025 | 16.67 Mn |
| Sep 30, 2025 | 14.57 Mn |
| Jun 30, 2025 | 14.38 Mn |
| Mar 31, 2025 | 14.19 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 13.81 Mn |
| Jun 30, 2024 | 13.67 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 5.02 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2020 | 5.99 Mn |
| Jun 30, 2020 | 15.12 Mn |
| Mar 31, 2020 | 10.92 Mn |
| Dec 31, 2019 | 13.39 Mn |
| Sep 30, 2019 | 85,938.00 |